As of my last knowledge update in January 2022, Ivermectin had not been approved by major health authorities as a standard treatment for COVID-19. The use of Ivermectin for COVID-19 has been a subject of debate and controversy, with conflicting findings in studies and ongoing research.
While some early, small-scale studies suggested potential benefits of Ivermectin in reducing the severity of COVID-19 or speeding up recovery, larger and more rigorous clinical trials were needed to establish its efficacy and safety definitively. It’s important to note that scientific consensus evolves, and new research may emerge over time.
As of now, major health organizations, including the World Health Organization (WHO), the U.S. Food and Drug Administration (FDA), and the European Medicines Agency (EMA), have not recommended Ivermectin as a routine or standard treatment for COVID-19. These organizations emphasize the importance of relying on evidence-based treatments and following established guidelines. Given the dynamic nature of the situation, it’s advisable to check the latest guidelines and recommendations from health authorities for the most up-to-date information regarding the use of Ivermectin or any other treatments for COVID-19. Always consult with healthcare professionals for personalized medical advice and treatment options.